Change in classification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets (ARM 87)
MHRA is seeking views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy to general sale list.
Detail
This consultation seeks your views on the reclassification of Galpharm Period Pain Relief 250mg Gastro-Resistant Tablets from pharmacy (P) to general sale list (GSL).
Please comment on the proposal in the document above using the reply form that is included.
Comments should be sent to MHRA by 17 March 2014. Comments received after that date will not be considered.
Documents